Cleared Traditional

K220877 - Selecta Duet LED

K220877 is an FDA 510(k) clearance for Selecta Duet LED, manufactured by Lumenis Be, Inc.. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K220877 · Lumenis Be, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
112d
Days
Class 2
Risk

K220877 is an FDA 510(k) clearance for the Selecta Duet LED, Digital Duet, Selecta LED Trio, Digital Trio Laser Systems. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Lumenis Be, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on July 15, 2022 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Lumenis Be, Inc. devices

FDA 510(k) Submission Details - K220877

510(k) Number K220877 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2022
Decision Date July 15, 2022
Days to Decision 112 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 110d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 96
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K220877.
Iridex PASCAL® 532, Iridex PASCAL® 577, Iridex PASCAL® (532nm and 577 nm models)
K223132 · Iridex Corporation · Nov 2022
Tango Neo, Tango Reflex Neo, Ultra Q Reflex Neo
K222395 · Ellex Medical Pty, Ltd. · Nov 2022
ECHO Photocoagulator
K222157 · Norlase · Oct 2022
Capsulo
K220430 · Quantel Medical · May 2022
Iridex 810 Laser
K213592 · Iridex Corporation · Mar 2022
Tango, Tango Reflex, Ultra Q, Ultra Q Reflex, Solo
K212630 · Ellex Medical Pty, Ltd. · Dec 2021